Author: Patricia Khashayar

“BioGeMT Project – Recruitment of the Team which will support the ERA Chair holderThe ERA Chair Team for this project will involve the recruitment of:(i) Researchers to perform Bioinformatics research, data analysis,...
Iryna Khrystoforova has just finished her PhD at Bar-Ilan University, Azrieli Faculty of Medicine under supervision of Prof. Karasik, Genetics of musculoskeletal diseases lab. Currently she is a Postdoc at...
Ines Alves is the founder and president of ANDO Portugal, the Skeletal Dysplasia National Association as well as the representative of the European Patient Advocacy groups (ePAG) and many other...
Artemis GKITAKOU, Research Assistant of Erasmus MC with main interests in life style and bone health.. Here, you can find her experience from participating in the GEMSTONE Mobility project: My...
4 postdoc positions to join the ERA-Net project IMMOSCAN and work on the role of immune osteoclasts in cancer – implications for therapy.
STSM and VNT call 2022 opens today. Application deadline: 2 October 2022 The applications will be evaluated by the Grant Awarding Coordinator and supported by the Grant Awarding Committee members....
Applications should be submitted at bonesecr@strutture.univaq.it and should include a detailed CV with a complete list of publications and other relevant achievements.Place of Work: University of L’Aquila, Italy, Department of...
We are seeking a highly motivated post-doctoral researcher interested in osteo-immunology to join our team and work on the diversity of osteoclasts, the multinucleated monocytic cells involved in bone resorption.We...
THREE ITC GRANTS are available for PhD students and Young Researchers and Innovators (YRI) that are WG members of GEMSTONE  from COST Inclusiveness Target Countries (ITC) and Near Neighbor Country (NNC)....
The EIC Transition 2022 (HORIZON-EIC-2022-TRANSITION-01) call, which has opened on March 1st, is intended to meet the following specific objectives: Advance, beyond the state-of-the-art, RNA delivery methods, including robust mRNA formulations, that would...